May 09, 2022 / 09:00PM GMT
Operator
Welcome to the Aptose Biosciences Inc. Reports Result for the First Quarter 2022 Conference Call. My name is Darryl, and I will be your operator for today's call. (Operator Instructions) As a reminder, this conference is being recorded.
I will now turn the call over to Dan Ferry. Dan, you may begin.
Daniel Ferry - LifeSci Advisors, LLC - MD & Relationship Manager
Thank you. Good afternoon, and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the first quarter ended March 31, 2022. Earlier today, Aptose issued a press release relating to these financial results. The news release, as well as related SEC filings are accessible on Aptose's website. Joining me on today's call are Dr. William G. Rice, Chairman, President and CEO; and Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer.
Before we proceed, I would like to remind everyone that certain statements made during this call will include forward-looking statements within the meaning of U.S. and Canadian securities laws. Forward
Q1 2022 Aptose Biosciences Inc Earnings Call Transcript
May 10, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers